For too long, the aesthetic medicine industry has designed and tested its most promising technologies primarily on lighter skin tones. The result? Treatments that carry real risks of post-inflammatory hyperpigmentation, burns, or uneven outcomes for patients with melanin-rich skin. It is a gap that has left millions of people of color either undertreated or overtreated — and deeply distrustful of new technologies claiming to be “for everyone.”
Sofwave is different — and the science explains why.
Fitzpatrick skin types IV through VI — which encompass many people of African, South Asian, East Asian, Middle Eastern, and Latin American descent — contain higher concentrations of melanin in the epidermis. Melanin is a natural photoprotector, which is part of why darker skin tones tend to age more slowly. But it also means that heat-based energy devices targeting the skin’s surface can absorb unevenly, raising the risk of burns, blistering, or the paradoxical darkening known as post-inflammatory hyperpigmentation (PIH).
This concern applies to many popular laser resurfacing treatments and even some radiofrequency devices that deliver energy at or near the epidermal layer. The history of aesthetic technology includes real, documented harm to patients with darker skin tones, and acknowledging that history is important.
Sofwave’s SUPERB (Synchronous Ultrasound Parallel Beam) technology targets the mid-dermal layer at a precise depth of 1.5mm — safely beneath the epidermis where melanin resides. The ultrasound energy does not interact with pigment at all. It passes through the skin’s surface layers without absorbing into melanocytes, producing collagen-stimulating thermal zones in the dermis without putting the epidermis at risk.
This is a fundamental difference from photothermal technologies (light-based or laser treatments) where melanin absorption is the mechanism of action. Sofwave is an ultrasound-based treatment: melanin is simply not part of the equation.
At Skin 22 Concierge, inclusivity is not a marketing statement — it is a clinical commitment. The team has extensive experience treating patients across all six Fitzpatrick skin types and uses Sofwave as a cornerstone treatment for patients with melanin-rich skin who deserve access to safe, effective technology.
Clinical studies supporting Sofwave’s FDA clearance included patients across a range of skin tones, and the treatment has demonstrated consistent safety and efficacy across diverse populations. No significant adverse events related to skin tone have been reported in clinical trials, further supporting its suitability for patients of color.
For individuals who have been burned — literally or figuratively — by laser treatments that caused pigmentation issues, Sofwave presents a genuinely new category of option. It is not simply a ‘safer laser.’ It operates on an entirely different physical principle.
Skin laxity is a universal aging concern that Sofwave addresses effectively regardless of skin tone. But for patients of color in particular, maintaining the integrity of the skin surface while improving firmness is essential. Any treatment that risks PIH may leave patients with a cosmetic concern worse than the one they came in to address.
Sofwave provides meaningful improvement in jowl laxity, brow position, neck skin tightening, and fine lines — all without surface disruption. For patients who are managing hyperpigmentation alongside laxity concerns, this allows them to address laxity without the fear of triggering additional pigmentation issues.
Before any aesthetic treatment, patients of color should feel empowered to ask their provider directly about their experience treating melanin-rich skin. Questions worth asking include: Have you treated my Fitzpatrick skin type before? What adverse events, if any, have you seen in patients with my skin tone? How does this technology interact with melanin?
A knowledgeable provider should answer these questions with specificity and confidence. If they cannot, that is important information.
Skin 22 Concierge prioritizes transparent, education-forward consultations. Your provider will walk you through exactly how Sofwave works, why it is safe for your skin tone, and what realistic outcomes you can expect — without minimizing your concerns or history with other treatments.
While Sofwave itself poses no pigmentation risk, post-treatment sun protection is universally important. For patients of color who are managing existing hyperpigmentation alongside their Sofwave treatment, a tyrosinase-inhibiting skincare protocol — incorporating ingredients like tranexamic acid, kojic acid, niacinamide, or azelaic acid — can be incorporated alongside the treatment timeline.
The best aesthetic treatments are the ones accessible to everyone. Sofwave’s mechanism of action makes it one of the most skin-tone-inclusive firming and lifting technologies available today. If you have been holding back from exploring non-invasive skin tightening because of well-founded concerns about treatments designed for lighter skin, Sofwave and a well-chosen provider change the conversation entirely.
